• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Antidepressant Use in Children, Adolescents, and Adults

[5/2/2007] The U.S. Food and Drug Administration (FDA) today proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during initial treatment (generally the first one to two months).

 

List of Antidepressant Drugs with Medication Guides

Anafranil (clomipramine) 
Asendin (amoxapine)
Aventyl (nortriptyline)
Celexa (citalopram hydrobromide) 
Cymbalta (duloxetine) 
Desyrel (trazodone HCl)
Elavil (amitriptyline) 
Effexor (venlafaxine HCl)
Emsam (selegiline)
Etrafon (perphenazine/amitriptyline)
fluvoxamine maleate
Lexapro (escitalopram oxalate)
Limbitrol (chlordiazepoxide/amitriptyline) 
Ludiomil (maprotiline) 
Marplan (isocarboxazid)
Nardil (phenelzine sulfate) 
nefazodone HCl
Norpramin (desipramine HCl) 
Pamelor (nortriptyline) 
Parnate (tranylcypromine sulfate) 
Paxil (paroxetine HCl) 
Pexeva (paroxetine mesylate) 
Prozac (fluoxetine HCl)
Remeron (mirtazapine) 
Sarafem (fluoxetine HCl) 
Seroquel (quetiapine)
Sinequan (doxepin)
Surmontil (trimipramine) 
Symbyax (olanzapine/fluoxetine)
Tofranil (imipramine) 
Tofranil-PM (imipramine pamoate) 
Triavil (perphenazine/amitriptyline)
Vivactil (protriptyline) 
Wellbutrin (bupropion HCl)
Zoloft (sertraline HCl) 
Zyban (bupropion HCl)

For more information on some of these drugs, please see the Index to Drug-Specific Information.

Historical Information on Antidepressant Use in Children, Adolescents, and Adults